NEW YORK (GenomeWeb) — Diagnostic tools developer Protagen AG announced this week that it will join the RA-MAP Consortium, a collaboration of 10 universities and 10 companies working together to identify the key predictors of clinical response and remission in rheumatoid arthritis (RA) patients, and to identify those at high risk of developing the disease. Protagen will contribute its proprietary SeroTag diagnostic platform to search for RA biomarkers.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.